Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Magnesium Sulphate (25% w/v) Injection
Therapeutic Category
Cardiovascular, Neurology, Cardiology
Dosage Form
Injection
Packaging Type
Vial
Packaging
10x5x2ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Megatome Injection (Magnesium Sulphate 25% w/v) is a high-profit, institutional product built for our PCD Pharma Franchise partners.
This essential electrolyte is a must-have in emergency and critical care settings (Obstetrics, Neurology, Cardiology), ensuring stable, non-seasonal demand.
Why Megatome Injection is Your Key to Profit:
Stable, High Demand: Magnesium Sulphate is critical for treating pre-eclampsia, eclampsia (seizures), acute asthma, and severe magnesium deficiency. Its use in hospital and ICU settings guarantees consistent and high-volume orders.
Specialty Market Margin: Since this is a specialized injectable, it commands excellent pricing and secures some of the highest profit margins within the critical care segment.
Reliable Quality: Our 25% w/v formulation meets all institutional quality benchmarks, building doctor and hospital purchasing trust for long-term supply contracts.
Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition in your designated hospitals and institutions. Partner with us for full marketing and tender support to convert this high-value product into guaranteed sales growth.
Contact us today to capture this high-margin specialty segment!
Common side effects may include flushing, warmth, sweating, mild hypotension, or transient dizziness during administration. Rarely, high doses may lead to muscle weakness, respiratory depression, or heart rhythm disturbances. Any severe reactions should be treated immediately under medical supervision.
Megatome Injection is indicated for treatment and prevention of magnesium deficiency, hypomagnesemia, eclampsia and pre-eclampsia in pregnant women, cardiac arrhythmias, and conditions associated with muscle spasms or tetany. It may also be used as part of therapy for certain neurological or cardiovascular disorders, as advised by a healthcare professional.
This injection should be administered only under medical supervision. Monitor patients for vital signs, kidney function, and serum magnesium levels during therapy. Caution is required in patients with renal impairment, heart block, or myasthenia gravis. Avoid rapid intravenous administration as it may cause adverse cardiovascular effects.
Store Megatome Injection in a cool, dry place below 25°C, protected from light. Keep the vial tightly closed and out of reach of children. Do not use after the expiry date mentioned on the packaging.
Composition : Cefixime (100mg)
Composition : Cefixime (200mg) + Cloxacillin (500mg) + Lactobacillus (90Million spores)
Composition : Cefixime 200mg + Clarithromycin 250mg Tablets
Composition : Cefixime (200mg) + Dicloxacillin (500mg) ER Tablet
Composition : Cefixime (50mg) + Ofloxacin (50mg)
Composition : Cefixime (50mg/5ml) + Clavulanic Acid (31.25mg/5ml)
Composition : Moxifloxacin (400mg) + Cefixime (400mg)
Composition : Cefixime (200mg) + Ofloxacin (200mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Magnesium Sulphate 25% w/v Injection is a critical-care injectable formulation widely used in obstetrics, gynecology, emergency medicine, and hospital settings. It is commonly prescribed for the management of severe pre-eclampsia, eclampsia, hypomagnesemia, certain cardiac arrhythmias, and other acute medical conditions. It is a strong hospital and critical-care segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand from hospitals, maternity centers, emergency departments, and intensive care units. As an essential injectable medicine in critical-care management, it generates regular institutional procurement and repeat orders.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for critical-care and injectable formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady hospital demand, institutional procurement, emergency care usage, and continuous consumption in maternity and critical-care settings when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this critical-care injectable formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, product availability, and distribution support services.